162 related articles for article (PubMed ID: 7728773)
1. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide.
Kato M; Hirose K; Hakozaki M; Ohno M; Saito Y; Izutani R; Noguchi J; Hori Y; Okumoto S; Kuroda D
Cancer Immunol Immunother; 1995 Mar; 40(3):152-6. PubMed ID: 7728773
[TBL] [Abstract][Full Text] [Related]
2. Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells.
Hirose K; Zachariae CO; Oppenheim JJ; Matsushima K
Lymphokine Res; 1990; 9(4):475-83. PubMed ID: 2090874
[TBL] [Abstract][Full Text] [Related]
3. Stimulation by PSK of interleukin-1 production by human peripheral blood mononuclear cells.
Sakagami H; Sugaya K; Utsumi A; Fujinaga S; Sato T; Takeda M
Anticancer Res; 1993; 13(3):671-5. PubMed ID: 8317896
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K.
Habelhah H; Okada F; Nakai K; Choi SK; Hamada J; Kobayashi M; Hosokawa M
Cancer Immunol Immunother; 1998 Aug; 46(6):338-44. PubMed ID: 9756418
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
[TBL] [Abstract][Full Text] [Related]
7. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
Sugimachi K; Maehara Y; Kusumoto T; Okamura T; Korenaga D; Kohnoe S; Baba H; Anai H
Anticancer Res; 1995; 15(5B):2175-9. PubMed ID: 8572620
[TBL] [Abstract][Full Text] [Related]
8. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
Okuzawa M; Shinohara H; Kobayashi T; Iwamoto M; Toyoda M; Tanigawa N
Int J Oncol; 2002 Jun; 20(6):1189-95. PubMed ID: 12011998
[TBL] [Abstract][Full Text] [Related]
9. Tumor cytostasis mediated by LPS- or PSK-activated human plastic-adherent peripheral blood mononuclear cells.
Kobayashi Y; Yoshikawa T; Watanabe N
Cell Immunol; 1992 Oct; 144(2):358-66. PubMed ID: 1394447
[TBL] [Abstract][Full Text] [Related]
10. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
11. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
12. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients.
Kanazawa M; Yoshihara K; Abe H; Iwadate M; Watanabe K; Suzuki S; Endoh Y; Takita K; Sekikawa K; Takenoshita S; Ogata T; Ohto H
Anticancer Res; 2005; 25(1B):443-9. PubMed ID: 15816609
[TBL] [Abstract][Full Text] [Related]
13. [Induction of manganese superoxide dismutase by an immunopotentiator as a mechanism of inhibiting of malignant progression of murine tumor cells].
Habelhah H
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):519-29. PubMed ID: 9846281
[TBL] [Abstract][Full Text] [Related]
14. Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling.
Asai H; Iijima H; Matsunaga K; Oguchi Y; Katsuno H; Maeda K
Cancer Immunol Immunother; 2008 Nov; 57(11):1647-55. PubMed ID: 18343922
[TBL] [Abstract][Full Text] [Related]
15. Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells.
Chang LY; Wan HC; Lai YL; Kuo YF; Liu TY; Chen YT; Hung SL
J Periodontal Res; 2009 Apr; 44(2):175-83. PubMed ID: 18973534
[TBL] [Abstract][Full Text] [Related]
16. Induction of gene expression for nitric oxide synthase by immunomodulating drugs in the RAW264.7 murine macrophage cell line.
Asai K; Kato H; Kimura S; Mukai S; Kawahito Y; Sano H; Kondo M; Akaogi K; Hirose K
Cancer Immunol Immunother; 1996 Jun; 42(5):275-9. PubMed ID: 8706048
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor-alpha induction.
Ohmura Y; Matsunaga K; Motokawa I; Sakurai K; Ando T
Int Immunopharmacol; 2001 Sep; 1(9-10):1797-811. PubMed ID: 11562071
[TBL] [Abstract][Full Text] [Related]
19. In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Imai S; Tobe T
Cancer Immunol Immunother; 1991; 32(6):335-41. PubMed ID: 1901030
[TBL] [Abstract][Full Text] [Related]
20. Contribution of cytokines on the suppression of lung metastasis.
Ishihara Y; Iijima H; Matsunaga K
Biotherapy; 1998; 11(4):267-75. PubMed ID: 9950103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
